U.S. Markets closed

Biosino Bio-Technology and Science Incorporation (8247.HK)


HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
2.95+0.11 (+-0.95%)
At close: 3:42PM HKT

Biosino Bio-Technology and Science Incorporation

No. 27, Chaoqian Road
Science and Technology Industrial Park
Beijing 102200
China
86 10 6972 2840
http://www.sinobio.com.cn

SectorHealthcare
IndustryBiotechnology
Full Time Employees542

Key Executives

NameTitlePayExercisedAge
Prof. Lebin WuChairman, Compliance Officer and Director of Baiao Pharmaceuticals156.25kN/A55
Mr. Chen JintianVice-Chairman, Chief Exec. Officer and Pres93kN/A39
Dr. Cunmao XuVP, Sec. and Exec. Director95.9kN/A54
Mr. Haitao ZhangVP and Exec. Director106.63kN/A44
Mr. Woon Cheung Tung CPA, CPA, (U.S)Company Sec.N/AN/A46
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagent products primarily in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; analyzers, such as flow cytometers and clinical chemistry analyzers; Elisa kits; and rapid tests. It also provides medical and medical inspection services; produces medical instruments; distributes immunodiagnostic products; and offers investment management services, as well as consulting services related to non-securities business and equity investment management. The company also exports its products to approximately 40 countries in Asia, Africa, and East Europe. Biosino Bio-Technology and Science Incorporation was founded in 1988 and is based in Beijing, the People’s Republic of China.

Corporate Governance

Biosino Bio-Technology and Science Incorporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.